BIOMAT Database Logo BIOMAT Database Logo

Low-dose cyclosporine or azathioprine one year after renal transplantation. 1987

M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Renal Unit, Western Infirmary, Glasgow, Scotland.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
March 2007, Transplantation,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Growth in children after liver transplantation on cyclosporine alone or in combination with low-dose azathioprine.
August 1993, Transplantation proceedings,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Withdrawal of cyclosporine treatment one year after renal transplantation.
June 1985, Transplantation,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Ten-year experience with low-dose cyclosporine A in renal transplantation.
October 1994, Transplantation proceedings,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Low-dose cyclosporine monotherapy in renal transplantation.
October 1987, Transplantation proceedings,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Low-dose cyclosporine for cadaveric renal transplantation.
February 1988, Transplantation,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Improved early course after cadaveric renal transplantation by reducing the cyclosporine dose and adding azathioprine.
February 1987, Transplantation proceedings,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
April 1987, Transplantation proceedings,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
November 1998, Transplantation,
M A Forwell, and J A Bradley, and J D Briggs, and M W Brown, and B J Junor, and S G Macpherson, and M A Watson
Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
February 1987, Transplantation proceedings,
Copied contents to your clipboard!